Recent guidelines have restricted aspirin use for primary cardiovascular disease prevention, with the AHA/ACC restricting it to patients under 70 and the U.S. Preventive Services Task Force further ...

New research further solidifies findings that aspirin could be a powerful anti-cancer drug, at least in some specific cases.

Current guidelines restricting aspirin based on age alone may be flawed; researchers argue decisions should be based on individual cardiovascular risk rather than arbitrary age cutoffs. The ASPREE ...

A check mark. It indicates that the relevant content has been reviewed and verified by an expert Our stories are reviewed by medical professionals to ensure you get the most accurate and useful ...

A new perspective challenges recent restrictions on aspirin for preventing heart attacks and strokes in healthy people, ...

Today, major medical groups say that aspirin should not be used by everyone to lower blood pressure. Instead, they recommend ...

Aspirin's benefit comes at a cost -- an increased ... And there's no sure way to predict if or when it will happen. "No medicine is innocuous," says Terry Jacobson, MD, director of the Office ...

A new study found a correlation between regular use of a popular over the counter drug and a decreased risk in certain types ...

Further trials comparing aspirin with newer anticoagulants (dabigatran ... in stroke prevention in patients with AF. 1 Department of Medicine, University of Wisconsin School of Medicine and ...

Researchers from Florida Atlantic University's Schmidt College of Medicine, and other distinguished collaborators who have led major trials of aspirin in primary prevention, have published their ...